Seth Klarman portfolio · Q2 2013
The Baupost Group, L.L.C. · CIK 0001061768 ·13F filings on SEC EDGAR
In Q2 2013, The Baupost Group, L.L.C. reported 24 positions worth $4B. Its largest holding was VSAT at 19.5% of the portfolio, and the top 10 made up 92%. This is the earliest quarter available here, so changes are not shown.
Portfolio map
Each box is a position sized by its value. There is no previous quarter here to compare changes.
Holdings
Click a holding to see its price chart with the quarters the investor bought or sold.
| Name | Weight | Avg. cost (est.) | Latest price | Gain/loss | Value |
|---|---|---|---|---|---|
VSAT VIASAT INC | 19.54% | $71.46* | $70.38 | -1.5% | $774.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BP BP PLC-SPONS ADR | 19.30% | $41.74* | $43.99 | +5.4% | $818.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
88338T104 THERAVANCE INC | 15.84% | $38.53* | $10.54 | -72.6% | $174.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MU MICRON TECHNOLOGY INC | 14.79% | $14.33* | $1,065.11 | +7,332.7% | $44.2B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AIG AMERICAN INTERNATIONAL GROUP | 11.25% | $44.70* | $74.42 | +66.5% | $753.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ROVI ROVI CORP | 3.50% | $22.84* | $19.48 | -14.7% | $120M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
IDIX IDENIX PHARMACEUTICALS LLC | 2.40% | $3.61* | $23.81 | +559.4% | $637.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
| 1.97% | — | — | — | $79.4M | |
C.WS.A CITIGROUP INC-CW19 | 1.84% | $0.79* | $0.15 | -80.7% | $14.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ORCL ORACLE CORP | 1.82% | $30.71* | $137.30 | +347.1% | $327.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
G2110R114 CHIPMOS TECH BERMUDA LTD | 1.33% | $19.35* | $19.80 | +2.3% | $54.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
NG NOVAGOLD RESOURCES INC | 1.14% | $2.11* | $6.50 | +208.1% | $141M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ELOS SYNERON MEDICAL LTD | 0.87% | $8.70* | $10.95 | +25.9% | $43.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AUY YAMANA GOLD INC | 0.77% | $9.51* | $5.85 | -38.5% | $19M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
018772103 ALLIANCE ONE INTL INC | 0.72% | $3.80* | $1.10 | -71.1% | $8.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CPF CENTRAL PACIFIC FINANCIAL CO | 0.67% | $18.00* | $35.89 | +99.4% | $53.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ITRN ITURAN LOCATION AND CONTROL | 0.44% | $16.87* | $51.22 | +203.6% | $53.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
293904108 ENZON PHARMACEUTICALS INC | 0.38% | $2.00* | $0.47 | -76.5% | $3.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
| 0.38% | — | — | — | $15.2M | |
AIG.WS AMERICAN INTERNATIONAL-CW21 | 0.30% | — | $0.16 | — | $105K |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
KGC KINROSS GOLD CORP | 0.27% | $5.10* | $24.08 | +372.1% | $50.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
053588109 AVEO PHARMACEUTICALS INC | 0.24% | $2.50* | $2.26 | -9.6% | $8.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
66988K102 NOVACOPPER INC | 0.22% | $1.75* | $0.50 | -71.4% | $2.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PVG PRETIUM RESOURCES INC | 0.03% | $6.63* | $14.09 | +112.3% | $2.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Jun 30, 2013, when our collected history starts, so the average starts from that quarter's price.
SEC filings for Q2 2013
- 13F-HR 0001140361-13-032160 · accepted Aug 13, 2013, 22:00 UTC